Referenced in: none

Automatically associated channels: Kir2.3

Title: The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo.

Authors: Kai Zhu, Su-Na Yang, Fen-Fen Ma, Xian-Feng Gu, Yi-Chun Zhu, Yi-Zhun Zhu

Journal, date & volume: PLoS ONE, 2015 , 10, e0119477

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/25909998

Abstract
In this paper, an analogue of hirsutine (compound 1) has been synthesized and evaluated as an anti-hypertension agent, which exhibits extraordinary effects on the contractile response of thoracic aorta rings from male SD rats in vitro (IC50 = 1.129×10(-9)±0.5025) and the abilities of reducing the systolic blood pressure (SBP) and heart rate (HR) of SHR in vivo. The mechanism investigation reveals that the vasodilatation induced by compound 1 is mediated by both endothelium-dependent and -independent manners. The relaxation in endothelium-intact aortic rings induced by compound 1 can be inhibited by L-NAME (1×10(-6) mol•L(-1)) and ODQ (1×10(-6) mol•L(-1)). Moreover, compound 1 can also block Ca2+ influx through L-type Ca2+ channels and inhibit intracellular Ca2+ release while no effect on K+ channel has been observed. All these data demonstrated that the NO/cyclic GMP pathway can be involved in endothelium-dependent manner induced by compound 1. Meanwhile the mechanism on the vasodilatation of compound 1 probably also related to blockade of Ca2+ influx through L-type Ca2+ channels and inhibition of intracellular Ca2+ release may have no relationship with K+ channels.